Clinical Core

$231,444U19FY2010AINIH

Univ Of Massachusetts Med Sch Worcester, Worcester MA

Investigators

Linked publications & trials

Paper 28802204 Paper 27443614 Paper 26934728 Paper 26599878 Paper 26439909 Paper 26150428 Paper 25497702 Paper 25141276 Paper 25125497 Paper 25081912 Paper 25002588 Paper 25002586 Paper 24965456 Paper 24762312 Paper 24717117 Paper 24606696 Paper 24583195 Paper 24510891 Paper 24480930 Paper 24457169 Paper 24127554 Paper 24126075 Paper 23941420 Paper 23886073 Paper 23667112 Paper 23284680 Paper 23238076 Paper 23228123 Paper 23149581 Paper 23001690 Paper 22966084 Paper 22953050 Paper 22894961 Paper 22875973 Paper 22718815 Paper 22523590 Paper 22384859 Paper 22357271 Paper 22355570 Paper 22296093 Paper 22206014 Paper 22133274 Paper 22104646 Paper 22101158 Paper 21994454 Paper 21921208 Paper 21829595 Paper 21655106 Paper 21460213 Paper 21339837 Paper 21335561 Paper 21328391 Paper 21220275 Paper 21216868 Paper 21195803 Paper 20980510 Paper 20883162 Paper 20729210 Paper 20634998 Paper 20536361 Paper 20483407 Paper 20421879 Paper 20213733 Paper 20181713 Paper 20143946 Paper 20032806 Paper 19860674 Paper 19802382 Paper 19740333 Paper 19551822 Paper 19530939 Paper 19524006 Paper 19435418 Paper 19264674 Paper 18981164 Paper 18977404 Paper 18955096 Paper 18837790 Paper 18830408 Paper 18653464 Paper 18614638 Paper 18559930 Paper 18507432 Paper 18339461 Paper 18275279 Paper 18251991 Paper 17913827 Paper 17897725 Paper 17709475 Paper 17692881 Paper 17641066 Paper 17617623 Paper 17357051 Paper 17357046 Paper 17326843 Paper 17082628 Paper 17001675 Paper 16979772 Paper 16849555 Paper 16829305

Abstract

The Clinical Research Core will provide centralized, quality controlled services for specimen processing, regulatory protocol management, development of Standard Operating Procedures, and limited specialized assay testing to support the research of Projects 1,2,3 and 4. The core will be responsible for the identification, recruitment, and phlebotomy of individuals to support U19 research objectives as well as the regulatory oversight of IRB protocols related to U19 research. Through the efforts of research associates and technicians, the core will be responsible for the processing and storage of the blood and serum samples obtained. The core will be responsible for a Quality Control Materials program to provide services related to Quality assurance of reagents and assays used in U19 research. This would include the establishment and optimization of standardized protocols, the development of a centralized comprehensive repository of positive control cell lines, the establishment of subject registry related to immunological characteristics of interest and the performance of established T cell assays to determine antigen specificity of PBMC samples and reagents. In addition, the clinical research core will provide a limited number of HLA typings for each of the proposed U19 projects.

View original record on NIH RePORTER →